Skip to content
Screener

Rhythm Pharmaceuticals, Inc. RYTM Q1 2025 earnings

Reported May 7, 2025 · Before market open

Revenue$32.7MMiss by $10.6M
EPS-$0.81Miss by $0.12
Revenue estimate$43.3M
EPS estimate-$0.69

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$84.5M
EPS estimate-$0.72

Financials

Q1 2025

Income statement

See full
Revenue$32.7M+25.9%
Gross profit$29.1M+25.5%
Operating income-$47.0M+66.4%
Net income-$49.5M+65.0%
EPS (diluted)-$0.81+65.5%

Balance sheet

See full
Cash & equivalents$106.1M+98.6%
Total debt$113.6M+10,447%
Total equity$18.9M-69.2%
Total assets$386.7M+49.5%

Cash flow

See full
Operating cash flow-$40.4M+1.0%
CapEx$238.3K—
Free cash flow-$29.2M-2.4%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$3.35B+28.5%
Enterprise value$3.36B+31.4%
P/S24.5×-3.9×

Profitability

See full
Gross margin89.6%+1.2pp
Operating margin-126.1%-46.0pp
Net margin-123.3%-45.6pp
FCF margin-83.7%-23.9pp

Returns & leverage

See full
Return on equity-419%-3,176pp
Debt / equity6×+6.0×
Current ratio3.3×-1.1×

Segments

By segment

See full
Single reportable segment$32.7M+25.9%

By product

See full
License revenue-$5.0M—

FAQ

When did Rhythm Pharmaceuticals, Inc. report Q1 2025 earnings?
Rhythm Pharmaceuticals, Inc. (RYTM) reported Q1 2025 earnings on May 7, 2025 before market open.
What were Rhythm Pharmaceuticals, Inc.'s Q1 2025 revenue and EPS?
Rhythm Pharmaceuticals, Inc. reported revenue of $32.7M and eps of $-0.81 for Q1 2025.
Did Rhythm Pharmaceuticals, Inc. beat estimates in Q1 2025?
Revenue missed the consensus estimate of $43.3M by $10.6M. EPS missed the consensus estimate of $-0.69 by $0.12.
How did Rhythm Pharmaceuticals, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 25.9% from $26.0M a year earlier and eps grew 65.5% from $-2.35.
Where can I find Rhythm Pharmaceuticals, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001558370-25-006602) and the 10-Q periodic report (0001558370-25-006765) directly on SEC EDGAR. The filing index links above go to sec.gov.